Salbutamol temporarily increases the bronchial production of nitric oxide

P. Paredi, M. C. Mozzi, G. Invernizzi, R. Boffi, P. J. Barnes, S. Kharitonov (London, United Kingdom; Milan, Italy)

Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases
Session: Noninvasive evaluation of airway diseases
Session type: Electronic Poster Discussion
Number: 530
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Paredi, M. C. Mozzi, G. Invernizzi, R. Boffi, P. J. Barnes, S. Kharitonov (London, United Kingdom; Milan, Italy). Salbutamol temporarily increases the bronchial production of nitric oxide. Eur Respir J 2007; 30: Suppl. 51, 530

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled salbutamol significantly affects the bronchial production of nitric oxide in normal subjects
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008

Increased nitric oxide production by neutrophils in bronchial asthma
Source: Eur Respir J 2001; 17: 868-871
Year: 2001



Changes in nitric oxide production in patients with bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 588s
Year: 2007

Smoking decreases bronchial nitric oxide output
Source: Eur Respir J 2005; 26: Suppl. 49, 152s
Year: 2005

Reduced bronchial nitric oxide flux but unchanged alveolar nitric oxide concentration after exposure to hyperbaric hyperoxia
Source: Annual Congress 2010 - New diagnostic approaches in respiratory function
Year: 2010


Features of production nitric oxide at patients with a bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006

Nitric oxide is a poor bronchodilator but reduces release of leukotrienes in the peripheral airways
Source: Eur Respir J 2005; 26: Suppl. 49, 128s
Year: 2005

Onset of action of inhaled corticosteroids on bronchial and alveolar nitric oxide output
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020


The nitric oxide (NO) metabolites in monitoring and therapy of bronchial asthma
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011

Hyperinflation is associated with reduced nitric oxide production in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 226s
Year: 2005

Nasal nitric oxide
Source: Eur Respir Monogr 2010; 49: 71-81
Year: 2010


Exhaled nitric oxide in asthma
Source: Eur Respir Monogr 2010; 49: 32-44
Year: 2010


Buffering airway acid decreases exhaled nitric oxide levels in humans
Source: Eur Respir J 2004; 24: Suppl. 48, 578s
Year: 2004

Inhaled nitric oxide decreases pulmonary endothelial nitric oxide synthase expression and activity in normal newborn rat lungs
Source: ERJ Open Res 2016
Year: 2016


Mechanisms of decrease in fractional exhaled nitric oxide during acute bronchoconstriction
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010

An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004



Sputum induction leads to a decrease of exhaled nitric oxide unrelated to airflow
Source: Eur Respir J 2003; 22: 354-357
Year: 2003



Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma
Source: Eur Respir J 2001; 18: 635-639
Year: 2001



Exhaled nitric oxide values measured at 10ml/s influence assessments of bronchial nitric oxide flux
Source: Eur Respir J 2006; 28: Suppl. 50, 792s
Year: 2006

Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002